Please provide your email address to receive an email when new articles are posted on . The FDA has cleared a 225 cm radial access catheter for PAD atherectomy. Radial access may reduce bleeding risk ...

ProPublica reporters are looking into the booming business around peripheral artery disease, a condition that afflicts 6.5 million Americans over age 40. It’s caused when fatty plaque builds up in a ...

The increasing number of geriatric patients, diabetic patients, and the adoption of minimally invasive vascular technologies are changing the treatment landscape of PAD worldwide.Austin, Texas, Feb.

WASHINGTON, DC, UNITED STATES, October 30, 2025 /EINPresswire.com/ -- The CardioVascular Coalition (CVC) today commended the publication of a landmark paper providing ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

June 7, 2005 — The European Commission has approved an atherectomy device for the treatment of peripheral artery disease; Health Canada has approved a synthetic cartilage implant for the treatment of ...

After years of struggling to make real progress in its core atherectomy businesses, CSII is selling out to Abbott for $20/share in cash. Abbott is acquiring an established but likely slower-growing ...

Please provide your email address to receive an email when new articles are posted on . In adults with peripheral arterial disease, a directional atherectomy system significantly reduced vessel ...

DUBLIN--(BUSINESS WIRE)--The "Atherectomy Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis" report has been ...

New York, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "BRIC Atherectomy Procedures Outlook to 2025 - Coronary Atherectomy Procedures and Lower Extremity ...

FRANKLIN LAKES, N.J., May 28, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to initiate a patient data ...